Index Venture Life Associates Vi LTD Centessa Pharmaceuticals PLC Transaction History
Index Venture Life Associates Vi LTD
- $40 Million
- Q3 2022
A detailed history of Index Venture Life Associates Vi LTD transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Index Venture Life Associates Vi LTD holds 9,961,789 shares of CNTA stock, worth $159 Million. This represents 100.0% of its overall portfolio holdings.
Number of Shares
9,961,789
Previous 9,961,789
-0.0%
Holding current value
$159 Million
Previous $48.5 Million
17.45%
% of portfolio
100.0%
Previous 100.0%
Shares
1 transactions
Others Institutions Holding CNTA
# of Institutions
83Shares Held
96.6MCall Options Held
12.1KPut Options Held
3K-
Medicxi Ventures Management (Jersey) LTD20MShares$318 Million64.35% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$154 Million2.77% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.71MShares$91.1 Million1.82% of portfolio
-
First Light Asset Management, LLC Edina, MN4.78MShares$76.2 Million3.93% of portfolio
-
Perceptive Advisors LLC New York, NY3.93MShares$62.7 Million1.03% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.5B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...